SBC Medical Group Holdings Incorporated (NASDAQ:SBC – Get Free Report) shares saw an uptick in trading volume on Monday following a stronger than expected earnings report. Approximately 198,457 shares changed hands during mid-day trading, an increase of 52% from the average daily volume of 130,815 shares. The stock last traded at $6.5910 and had previously closed at $7.35.
The company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.12 by $0.03. SBC Medical Group had a return on equity of 19.14% and a net margin of 27.26%. The firm had revenue of $58.58 million during the quarter, compared to analyst estimates of $48.90 million.
Analysts Set New Price Targets
SBC has been the topic of a number of recent analyst reports. Weiss Ratings raised shares of SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, October 9th. BTIG Research raised their price target on shares of SBC Medical Group from $8.00 to $10.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Wall Street Zen cut shares of SBC Medical Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $10.00.
Check Out Our Latest Report on SBC Medical Group
Institutional Trading of SBC Medical Group
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Nisa Investment Advisors LLC acquired a new stake in shares of SBC Medical Group in the 3rd quarter valued at $36,000. Bank of New York Mellon Corp acquired a new stake in SBC Medical Group during the first quarter worth about $43,000. Bank of America Corp DE purchased a new position in shares of SBC Medical Group in the 2nd quarter worth about $35,000. Williams & Novak LLC raised its holdings in shares of SBC Medical Group by 31.2% in the 2nd quarter. Williams & Novak LLC now owns 18,686 shares of the company’s stock worth $58,000 after purchasing an additional 4,449 shares during the period. Finally, Deutsche Bank AG purchased a new position in shares of SBC Medical Group in the 2nd quarter worth about $58,000. 60.82% of the stock is currently owned by hedge funds and other institutional investors.
SBC Medical Group Stock Down 12.9%
The firm has a market capitalization of $658.22 million, a price-to-earnings ratio of 12.84, a price-to-earnings-growth ratio of 3.30 and a beta of 0.52. The company has a current ratio of 3.31, a quick ratio of 3.27 and a debt-to-equity ratio of 0.09. The firm has a 50 day moving average price of $5.13 and a two-hundred day moving average price of $3.98.
SBC Medical Group Company Profile
SBC Medical Group Holdings provides management and support services to medical institutions, with a focus on clinics offering aesthetic medicine. Its services include support for clinic operations, marketing, staff training, procurement and customer service, allowing affiliated medical providers to focus on patient care. The group is associated with the Shonan Beauty Clinic brand and a broader network of clinics offering services such as cosmetic surgery and dermatology. Its business is centered primarily in Japan, where it supports the operations and growth of affiliated medical institutions.
Featured Articles
- Five stocks we like better than SBC Medical Group
- Sandisk’s Sell-Off May Be Losing Steam, But the Biggest Risk Still Looms
- Meta’s Access to Capital Remains Strong, But Borrowing Is Becoming More Expensive
- 3 Large-Cap Stocks Are Outperforming the S&P 500 Without AI Hype
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
Receive News & Ratings for SBC Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SBC Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
